Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
998
-
Total 13F shares, excl. options
-
120M
-
Shares change
-
+549K
-
Total reported value, excl. options
-
$33.3B
-
Value change
-
+$172M
-
Put/Call ratio
-
1.2
-
Number of buys
-
420
-
Number of sells
-
-433
-
Price
-
$276.92
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2022
1,174 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2022.
BIOGEN INC. - Common Stock (BIIB) has 998 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120M shares
of 147M outstanding shares and own 81.69% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.7M shares), BlackRock Inc. (14.3M shares), VANGUARD GROUP INC (12M shares), STATE STREET CORP (6.81M shares), WELLINGTON MANAGEMENT GROUP LLP (5.41M shares), GEODE CAPITAL MANAGEMENT, LLC (3.34M shares), DEUTSCHE BANK AG\ (1.85M shares), Clearbridge Investments, LLC (1.81M shares), D. E. Shaw & Co., Inc. (1.76M shares), and NORTHERN TRUST CORP (1.67M shares).
This table shows the top 998 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.